Drug intelligence / Profile preview

ozone

Development stage
Phase 4
Modality
Small Molecules
Administration
Intraarticular, Rectal, Intravesical, Percutaneous, Topical
01

Overview

**Medical ozone** is ozone gas (O3), typically generated immediately before use from medical oxygen and administered as an ozone/oxygen gas mixture. It is an investigational therapeutic gas used in heterogeneous clinical protocols, including intra-articular injection for knee osteoarthritis and rectal insufflation for chemotherapy-induced peripheral neuropathy. Ozone is a highly reactive oxidant rather than a selective receptor-directed drug; proposed biological effects involve rapid reactions with biological fluids and lipids that produce transient reactive oxygen species and lipid-oxidation products, potentially activating endogenous antioxidant and anti-inflammatory response pathways. Clinical evidence remains variable by indication, route, concentration, and treatment schedule. In the United States, ozone is not an FDA-approved therapeutic drug, and federal regulation states that ozone is a toxic gas with no known useful medical application in specific, adjunctive, or preventive therapy. ([pubmed.ncbi.nlm.nih.gov](https://pubmed.ncbi.nlm.nih.gov/28738079/))

Other names
medical ozoneO3O-3O 3oxygen-ozone mixtureoxygen-ozone therapyozone therapy

Beyond the preview

Go deeper on ozone.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on ozone.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call